Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
30 Leser
Artikel bewerten:
(0)

Healthcare/Medical Simulation Market Worth $2,069.2 Million by 2019

DALLAS, October 20, 2014 /PRNewswire/ --

According to the new market research report the "Healthcare/Medical simulation Marketby Product (Patient Simulator, Surgical Simulator, Web-based Simulation, Simulation Software, Dental Simulator, Eye Simulator), End-User (Academics, Hospitals, Military) &byServices-Global Forecaststo 2019", published by marketsandmarkets,analyzes and studies the major market drivers, restraints, opportunities, challenges, and burning issues in North America, Europe, Asia-Pacific, and the Rest of the World.

Browse 173 Market Tables and 31 Figures spread through 250 Pageson "Healthcare/MedicalSimulation Market"
http://www.marketsandmarkets.com/Market-Reports/healthcare-medical-simulation-market-1156.html

Early buyers will receive 10% customization on this report.

This report studies the Healthcare/Medical Simulation Market over the forecast period of 2014 to 2019.

Healthcare/medical simulation improves patient outcomes, facilitates increased task proficiency and patient safety, reduces medical errors, and enhances professional communication and team management skills, which reduces the overall healthcare costs. Therefore, an increased number of medical schools, training centers, and military organizations are adopting simulation technologies. In addition, there is an increasing adoption of technologically advanced simulation systems to create clinical condition situations so that the actual operations on patients can be done with minimized errors. However, high costs of simulators, limited availability of funds, and operational challenges may restrain the growth of this market during the forecast period of 2014 to 2019.

Further Inquiry:http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1156

In this report, the Healthcare/Medical Simulation Market is segmented on the basis of different types of products and services, end users, and regions. This report also discusses the key market drivers, restraints, opportunities, and challenges for this market and its submarkets. The global Healthcare/Medical Simulation Market is expected to reach $2,069.2 Million by 2019 from $863.5 Million in 2014 and, at a CAGR of 19.1% from 2014 to 2019.

In 2013, North America was the major market for healthcare/medical simulation products and services, followed by Europe and Asia-Pacific. The highest market share of North America and European regions is primarily attributed to the presence and expansion of major healthcare/medical simulation companies through acquisitions which has improved the accessibility of healthcare/medical simulation products and services in this region. However, the future growth of the Healthcare/Medical Simulation Market will be driven by the Asia-Pacific and Latin American regions. This is mainly attributed to the continuous efforts of Asian economies toward the development of the healthcare sector in this region. These economies have modified regulations and monitored the implementation of procedures, policies, and guidelines to promote innovation and commercialization. This is attracting many homegrown entrepreneurs as well as global leaders to the region. The increasing number of hospitals, academic institutions, and medical devices propel the market for healthcare/medical simulation. Moreover, increasing focus on medical education, training, and research in India and China showcases great potential for the Healthcare/Medical Simulation Market in this region.

The major players in the Healthcare/Medical Simulation Market are CAE, Inc. (Canada), Laerdal Medical AS (Norway), 3D Systems, Inc. (U.S.), Simulab Corporation (U.S.), Simulaids, Inc. (U.S.), Limbs and Things, Ltd (U.K.), Kyoto Kagaku Co., Ltd (Japan), Mentice AB (Sweden), Surgical Science Sweden AB (Sweden), and Gaumard Scientific Company, Inc. (U.S.).

Browse related reports

Medical Image Analysis Software Market by Types (Integrated & Standalone), by Technology (X-ray, CT, Ultrasound, MRI, SPECT, PET), by Image (2D, 3D & 4D) & by Indications (Neurology, Cardiology, Radiology) - Global Trends, Opportunities & Forecast till 2017
http://www.marketsandmarkets.com/Market-Reports/medical-image-analysis-software-market-846.html

Practice Management System Market by Products (Integrated, Standalone), Components (Services, Software), Delivery Mode (On-Premises/Desktop-Only, Web-Based, Cloud-Based) & by End-Users (Physician, Pharmacist, Diagnostic Labs) - Global Trends & Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/medical-practice-management-software-market-886.html

About MarketsandMarkets

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog http://mnmblog.org/market-research/healthcare/healthcareit


© 2014 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.